Comparison of Hematological Parameters Between Survivors and Non-Survivors COVID-19 Patients in Saudi Arabia.

Naif K BinsalehReem EltayebSubuhi SherwaniAli A AlmishaalEmad A HindiHusam Qanash Abdulrahman S BazaidAbdulmajeed Owayed AlharbiMohammed B BazaidShayaa Alsaadi Altamimi

Published in: International journal of general medicine (2023)

Hematological parameters can serve as valuable indicators to identify patients with severe COVID-19 and expected poor-prognosis/outcomes upon hospital admission. Cell counts of lymphocytes, WBCs, basophils and parameters such as PT and PTT can serve as clinical indicators to assess disease severity and predict progression to critical illness.

Keyphrases

poor prognosis
sars cov
long non coding rna
coronavirus disease
young adults
emergency department
peripheral blood
healthcare
single cell
type diabetes
stem cells
early onset
cell therapy
skeletal muscle
metabolic syndrome
weight loss
drug induced